Lateral Flow Assay Components Companies

The global lateral flow assay (LFA) components market is projected to reach USD 486.2 million by 2030 from USD 392.4 million in 2025, at a CAGR of 4.4% during the forecast period.

LFA components are essential for quick diagnostic testing, point-of-care healthcare, and large-scale disease screening. These components include membranes, pads, conjugates, and other critical materials, all designed to ensure accurate analyte detection and dependable assay performance. Commonly used in clinical testing, veterinary diagnostics, food safety, and drug quality assessment, these components facilitate timely decisions and early disease detection. Their integration into complete test kits enables rapid, decentralized testing without complex laboratory setups, making them especially useful in home-based, resource-constrained, and field environments. Additionally, LFA components are produced in accordance with industry standards and regulatory requirements, guaranteeing high sensitivity, specificity, and reproducibility across various applications and end users—from hospitals and diagnostic laboratories to research institutions and commercial testing facilities.

Notable companies in this market include Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Ahlstrom (Finland), Advanced Microdevices Pvt. Ltd. (India), DCN Diagnostics (US), Fortis Life Sciences, LLC.  (US), Cobetter (China), Axiva Sichem Pvt. Ltd. (India), and Nupore Filtration Systems (India), among others. The leading companies in the market focus on higher sales, product launches, and product approvals.

To know about the assumptions considered for the study download the pdf brochure

Danaher Corporation (US) is a global leader in science and technology with a strong presence in the lateral flow assay components market, including membranes, pads, and nanoparticle solutions essential for manufacturing LFAs. The company has strategically expanded its portfolio through high-value acquisitions, notably Pall Corporation in 2015 (USD 13.8 billion) and the GE Biopharma business in 2020 (renamed Cytiva, acquired for USD 21 billion), significantly strengthening its expertise in membrane technology and diagnostic consumables. To further increase its global capacity, Danaher invested in Cytiva’s manufacturing expansion in Pune, India (2023), which included advanced equipment relevant to LFA component production, such as tangential flow and virus filtration systems. Through Cytiva, Danaher continues to deliver high-performance materials that enhance assay sensitivity, reproducibility, and scalability. The company mainly pursues growth through strategic acquisitions and infrastructure investments, ensuring ongoing innovation in diagnostic component manufacturing. These efforts have solidified Danaher’s position as a leading player in the global lateral flow assay components market, providing critical solutions that support point-of-care and rapid diagnostic testing worldwide.

Sartorius AG (Germany) is a leading global provider of bioprocess solutions and laboratory technologies, operating through two main segments—Bioprocess Solutions and Lab Products & Services. The latter supplies laboratory products, consumables, and analytical tools to pharmaceutical, biopharmaceutical, and academic research institutions. Within this division, Sartorius offers LFA components, particularly nitrocellulose membranes, which serve as the substrate for test and control line deposition. These membranes are valued for their reproducibility, consistency, and ability to meet the quality standards required in rapid diagnostic test manufacturing. Sartorius emphasizes technology-driven, customer-focused innovation and sustained R&D investment, allocating USD 212.9 million in 2024 to research and development. Expanding manufacturing capacity and expertise in filtration and fluid management further strengthen its support for assay developers with scalable, high-performance components. By combining scientific expertise with a broad distribution network, Sartorius has positioned itself as a trusted partner for the LFA ecosystem, supporting infectious disease diagnostics, food safety testing, and veterinary healthcare. These strengths establish Sartorius as a key contributor to innovation and growth in the global lateral flow assay components market.

Merck KGaA (Germany) is a leading global supplier of life science tools and technologies, operating through three divisions—Life Science, Healthcare, and Electronics. Its Life Science segment, further divided into Science & Lab Solutions, Process Solutions, and Life Science Services, supports biotech, pharmaceutical, academic, and industrial markets. Within this, the Science & Lab Solutions unit drives the company’s role in the lateral flow assay components market by providing essential materials for diagnostic test manufacturing. In 2024, Merck began constructing its first U.S. facility in Sheboygan, Wisconsin, dedicated to producing Hi-Flow Plus lateral flow membranes—key substrates for rapid diagnostic kits, including COVID-19 tests. Supported by a USD 136.7 million US Department of Defense contract, this initiative strengthens domestic supply chains and broadens Merck’s North American presence. By expanding capacity, enhancing supply security, and focusing on customer-driven innovation, Merck continues to solidify its competitive position in diagnostic components. Its dependable, high-performance membranes and consumables make it a trusted partner for diagnostic manufacturers worldwide and a key player in the global LFA components ecosystem.

Market Ranking

The global lateral flow assay components market is led by key players such as Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Ahlstrom (Finland), and Advanced Microdevices Pvt. Ltd. (India), who together hold a significant market share. Danaher Corporation maintains its leadership through strategic acquisitions, expanded manufacturing capabilities, and a diverse portfolio of membranes, pads, and conjugates. Sartorius AG boosts its position with high-quality nitrocellulose membranes, a strong focus on R&D, and technology-driven, customer-focused solutions. Merck KGaA leverages its Science & Lab Solutions division and U.S.-based manufacturing to support rapid diagnostic kit production. Ahlstrom is known for its innovative membrane materials and consistent product quality, while Advanced Microdevices Pvt. Ltd. benefits from regional expertise and increasing adoption in emerging markets. The market is highly competitive, driven by ongoing technological innovation, the growth of point-of-care testing, rising demand for home diagnostics, and the growing prevalence of infectious and chronic diseases worldwide.

Related Reports:

Lateral Flow Assay Components Market by Type (Membrane, Pad), Application (Clinical Testing (Infectious, Cardiac Marker Test, Fertility, Pregnancy, Cholesterol Testing), Veterinary, Food Safety), Technique, End User & Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com